High remnant lipoprotein levels in patients with variant angina

Kunihisa Miwa1, Toshinori Makita, Katsuhisa Ishii

  • 1Second Department of Internal Medicine, Kansai Electric Power Hospital, Osaka, Japan. ku-miwa@hamamatsuh.go.jp

Clinical Cardiology
|July 9, 2004
PubMed

Insights

Patients with active coronary vasospasm show higher remnant lipoprotein (RLP) levels and lower alpha-tocopherol, indicating disordered lipid metabolism and oxidative stress contribute to this condition.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Oxidative Stress

Background:

  • Dyslipidemia with increased oxidative stress, independent of LDL cholesterol, is implicated in coronary vasospasm pathogenesis.
  • Triglyceride-rich lipoprotein metabolism disorders may contribute to coronary artery spasm development.

Purpose of the Study:

  • To investigate the association between remnant lipoprotein (RLP) levels, alpha-tocopherol, and variant angina (VA) activity.
  • To explore the role of disordered triglyceride-rich lipoprotein metabolism and oxidative stress in coronary vasospasm.

Main Methods:

  • Serum remnant lipoprotein (RLP) and alpha-tocopherol levels were measured in patients with active VA, inactive VA, and control subjects.
  • Triglyceride, HDL cholesterol, and smoking prevalence were also assessed and compared among groups.

Main Results:

  • Active VA patients exhibited significantly higher RLP levels and lower alpha-tocopherol levels compared to inactive VA and control groups.
  • Higher RLP levels correlated positively with triglyceride levels and inversely with alpha-tocopherol.
  • Smoking was more prevalent in active VA patients.

Conclusions:

  • Active variant angina is associated with elevated RLP levels and reduced antioxidant capacity (alpha-tocopherol).
  • Disordered triglyceride-rich lipoprotein metabolism and increased oxidative stress are linked to coronary vasospasm activity and pathogenesis.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...